HIGH WYCOMBE, UK, 28th April 2005 – Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced that the European Commission has approved the use of VELCADE® (bortezomib) for ...
NEW YORK (Reuters) - Millennium Pharmaceuticals Inc Chief Executive Deborah Dunsire on Thursday said the company is upbeat on 2008 growth prospects for its Velcade cancer drug as it eyes approval as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback